Welcome to LookChem.com Sign In|Join Free
  • or
3-amino-1,2-dimethylimidazolium mesitylenesulfonate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

54558-30-4

Post Buying Request

54558-30-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

54558-30-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 54558-30-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,4,5,5 and 8 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 54558-30:
(7*5)+(6*4)+(5*5)+(4*5)+(3*8)+(2*3)+(1*0)=134
134 % 10 = 4
So 54558-30-4 is a valid CAS Registry Number.

54558-30-4Downstream Products

54558-30-4Relevant academic research and scientific papers

Targeting DNA with small molecules: A comparative study of a library of azonia aromatic chromophores

Surez, Rosa M.,Bosch, Pedro,Sucunza, David,Cuadro, Ana M.,Domingo, Alberto,Mendicuti, Francisco,Vaquero, Juan J.

, p. 527 - 538 (2015/02/19)

A library of azonia aromatic cations has been studied in order to gain insights into the effect of the size, shape and charge distribution on the fluorescence, DNA interactions and DNA sequence selectivity properties. Fluorescence-based thermal denaturation experiments, spectrofluorimetric titrations, circular dichroism measurements and theoretical simulations have shown that some of the studied chromophores have interesting fluorescence properties and two of them also show a consistent DNA-binding ability by intercalation, with a potential preference for AT-rich sequences.

Method for treating fibrotic diseases or other indications with imidazolium agents

-

, (2008/06/13)

Provided is a method of treating or ameliorating an indication of the invention in an animal, including a human, by administering an effective amount of a compound of the formula I: wherein R1, R2, M, X and Z are as described supra. Also provided are certain imidazolium compounds and pharmaceutical compositions containing the imidazolium compounds.

Method for treating fibrotic diseases or other indications IC

-

, (2011/07/06)

Provided, among other things, is a method of treating or ameliorating or preventing an indication of the invention in an animal, including a human comprising administering an effective amount of a compound of the formula I:

Westphal Condensation of N-Aminocycloiminium Salts. Synthesis of Fused Pyridazinium Derivatives

Matia, Maria P.,Garcia-Navio, Jose L.,Vaquero, Juan J.,Alvarez-Builla, Julio

, p. 777 - 780 (2007/10/02)

A series of α-alkyl-N-aminoazinium and -azolium salts 1-15 have been condensed with 1,2-dicarbonyl compounds to produce new heterocyclic cationic species 17-25 with a quaternary nitrogen atom in the bridgehead position.Key Words: Westphal condensation / N

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 54558-30-4